Tailored drug testing: a new way to match RA patients with their ideal medication
NCT ID NCT06016517
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study aims to learn which FDA-approved rheumatoid arthritis (RA) medication works best for each individual patient. Researchers will test four different drugs in a personalized sequence and track symptoms and quality of life through regular surveys. The goal is to improve treatment decisions for the 18 newly diagnosed participants with moderate to severe RA.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Conditions
Explore the condition pages connected to this study.